NURIX THERAPEUTICS IN
22.00
08-10月-24 14:59:59
15 分の遅延
株式
+0.46
+2.14%
本日の幅
21.30 - 22.72
ISIN
N/A
ソース
NASDAQ
-
06 10 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
05 10 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
14 9 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Participate in Upcoming Investor Conferences
31 8 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces Appointment of Eric Schlezinger, J.D. as Chief People Officer
03 8 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces $40 Million Registered Direct Offering
08 7 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces $55 Million Registered Direct Offering
07 7 2022 16:03:06 提供 Nasdaq GlobeNewswire
-
07 7 2022 15:05:00 提供 Nasdaq GlobeNewswire
-
30 6 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
10 6 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
03 6 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
26 5 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
17 5 2022 06:00:02 提供 Nasdaq GlobeNewswire
-
11 5 2022 15:02:00 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics to Host R&D Day on May 26, 2022
09 5 2022 15:02:00 提供 Nasdaq GlobeNewswire
-
08 4 2022 12:02:00 提供 Nasdaq GlobeNewswire
-
07 4 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
05 4 2022 06:00:01 提供 Nasdaq GlobeNewswire
-
Nurix Therapeutics Announces Participation in the 21st Annual Needham Virtual Healthcare Conference
04 4 2022 15:01:00 提供 Nasdaq GlobeNewswire
-
29 3 2022 15:01:00 提供 Nasdaq GlobeNewswire